Sernova Biotherapeutics (SVA.TO) Q2 2025 Earnings

Jun 13Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.04
-0.03
-0.02
-0.01

Details

Expected EPS
-0.02080155134736
Actual EPS
-0.009835248864
Surprise EPS
0.01
Surprise Percent
+52.72%

Description

⁨Sernova Biotherapeutics⁩ (⁦SVA.TO⁩) has reported earnings of ⁦-0.009835248864⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts